From YMB: Sorry been a hectic 2 months, I’m a
Post# of 148147
(Total Views: 665)
Posted On: 09/17/2021 5:22:27 AM
From YMB:
Sorry been a hectic 2 months, I’m afraid NP was taken out of context during the investor conference. I believe what he meant was that we will be having another webinar with a major hospital in the Philippines which will include the therapeutics committee of the hospital.
The US FDA public rebuke really put the brakes on the use of leronlimab here in the Philippines but you cant argue with a patient who walks out of the hospital, so more and more patients are asking for leronlimab.
Recently, a lot more doctors and hospitals are asking for leronlimab as well! Hence the additional PO’s. We are trying our best to compile the results from the Philippines so that Cytodyn, Inc can have more data to support leronlimab’s efficacy against severe critical COVID.
Richard S. Nicolas, MD
Congenital Cardiothoracic Surgery
Sorry been a hectic 2 months, I’m afraid NP was taken out of context during the investor conference. I believe what he meant was that we will be having another webinar with a major hospital in the Philippines which will include the therapeutics committee of the hospital.
The US FDA public rebuke really put the brakes on the use of leronlimab here in the Philippines but you cant argue with a patient who walks out of the hospital, so more and more patients are asking for leronlimab.
Recently, a lot more doctors and hospitals are asking for leronlimab as well! Hence the additional PO’s. We are trying our best to compile the results from the Philippines so that Cytodyn, Inc can have more data to support leronlimab’s efficacy against severe critical COVID.
Richard S. Nicolas, MD
Congenital Cardiothoracic Surgery
(15)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼